Related Experiment Video
Updated: May 18, 2026
Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
Published on: March 5, 2019
Differential expression of cell surface markers in response to 2,4-dinitrofluorobenzene in RAW 264.7 and primary
Dongbum Kim1, Min Chul Park, Byoung Kwon Park
1Department of Microbiology, College of Medicine, Hallym University, Chuncheon 200-702, Korea.
Insights
2,4-dinitrofluorobenzene (DNFB) alters macrophage molecule expression, including transient CD83 increases, but not CD86. This study investigates DNFB
Area of Science:
- Immunology
- Cell Biology
Background:
- Costimulatory molecules and MHC class II are crucial for immune responses.
- 2,4-dinitrofluorobenzene (DNFB) is a chemical agent used to study immune reactions.
- Macrophages play a significant role in immune regulation and inflammation.
Purpose of the Study:
- To investigate the effects of DNFB on the expression of CD80, CD83, CD86, and MHC class II in RAW 264.7 macrophages.
- To compare DNFB's effects on macrophages with its known effects on dendritic cells.
- To examine DNFB-induced changes in splenocytes and peritoneal cells from mice.
Main Methods:
- Utilized the RAW 264.7 macrophage cell line.
- Exposed cells to 2,4-dinitrofluorobenzene (DNFB).
- Analyzed the expression of CD80, CD83, CD86, and MHC class II using flow cytometry or similar techniques.
- Investigated primary cells from BALB/c and NC/Nga mice, including splenocytes and peritoneal CD11b(+) cells.
Main Results:
- DNFB induced CD80 and MHC class II expression in RAW 264.7 macrophages.
- CD86 expression remained unchanged in macrophages treated with DNFB.
- CD83 expression showed a transient increase followed by a decrease in macrophages.
- DNFB induced CD80 and MHC class II expression and decreased CD83 expression in mouse splenocytes.
- DNFB did not affect CD83 expression in peritoneal CD11b(+) cells from mice.
Conclusions:
- DNFB differentially affects costimulatory molecule and MHC class II expression in macrophages compared to dendritic cells.
- The transient nature of CD83 expression changes suggests complex regulatory mechanisms.
- Further in vivo studies are needed to clarify the role of CD11b(+) cells in atopic dermatitis pathogenesis.
Abstract:
We evaluated the expression of the costimulatory molecules CD80 and CD83 and major histocompatibility (MHC) class II induced by 2,4-dinitrofluorobenzene (DNFB) in the RAW 264.7 macrophage cell line. In contrast to the previously reported effect of DNFB on dendritic cells, CD86 expression did not change. Furthermore, we observed that the CD83 expression level transiently increased and then decreased. Induction of CD80 and MHC class II molecule expression and a decrease in CD83 expression by DNFB in vitro were also confirmed in splenocytes of BALB/c and NC/Nga mice. However, DNFB did not influence CD83 expression in peritoneal CD11b(+) cells from BALB/c or NC/Nga mice. Detailed in vivo experiments and further studies on the possible contribution of CD11b(+) cells to induce atopic dermatitis (AD) would be helpful to attain a better understanding of AD pathogenesis.
